Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Cancer”

1,868 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,868 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Post-approval studies (Phase 4)Ended earlyNCT01512472
What this trial is testing

Firmagon (Degarelix) Intermittent Therapy

Who this might be right for
Prostate Cancer Recurrent
Canadian Urology Research Consortium 144
Not applicableActive Not RecruitingNCT03234556
What this trial is testing

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

Who this might be right for
Health Status UnknownElevated PSA
University of Southern California 288
Not applicableNot Yet RecruitingNCT07040501
What this trial is testing

Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00639509
What this trial is testing

IMC-A12 in Treating Patients With Advanced Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00040898
What this trial is testing

Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed

Who this might be right for
Liver Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)UnknownNCT02037464
What this trial is testing

CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 100
Very early researchStudy completedNCT04301414
What this trial is testing

Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Columbia University 26
Early research (Phase 1)Looking for participantsNCT07179328
What this trial is testing

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Who this might be right for
GBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more
Sunnybrook Health Sciences Centre 10
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Testing effectiveness (Phase 2)Looking for participantsNCT05961709
What this trial is testing

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Who this might be right for
Colon Cancer
M.D. Anderson Cancer Center 50
Not applicableStudy completedNCT01971021
What this trial is testing

Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.

Who this might be right for
Focus of Study
Linkoeping University 400
Large-scale testing (Phase 3)UnknownNCT00003734
What this trial is testing

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
St. Luke's Hospital, Ireland 276
Early research (Phase 1)Ended earlyNCT03237572
What this trial is testing

Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Patrick Dillon, MD 13
Not applicableStudy completedNCT02238899
What this trial is testing

Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma

Who this might be right for
Medulloblastoma, ChildhoodCerebral Primitive Neuroectodermal TumorEpendymoma
Universitätsklinikum Hamburg-Eppendorf 354
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05373316
What this trial is testing

Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy

Who this might be right for
Prostate CancerProstate Neoplasm
Radboud University Medical Center 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT06392009
What this trial is testing

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Who this might be right for
Tuberous Sclerosis ComplexFocal Cortical Dysplasia
GRIN Therapeutics, Inc. 30
Not applicableLooking for participantsNCT06027632
What this trial is testing

Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer

Who this might be right for
Breast CancerCognitive Dysfunction
Centre Francois Baclesse 300
Load More Results